SK285724B6 - Použitie adenovírusového génového nosiča schopného indukovať apoptózu v bunke na prípravu liečiva na liečenie transformovaných buniek a na prípravu diagnostického prostriedku na diagnostikovanie transformovaných buniek - Google Patents

Použitie adenovírusového génového nosiča schopného indukovať apoptózu v bunke na prípravu liečiva na liečenie transformovaných buniek a na prípravu diagnostického prostriedku na diagnostikovanie transformovaných buniek Download PDF

Info

Publication number
SK285724B6
SK285724B6 SK1428-99A SK142899A SK285724B6 SK 285724 B6 SK285724 B6 SK 285724B6 SK 142899 A SK142899 A SK 142899A SK 285724 B6 SK285724 B6 SK 285724B6
Authority
SK
Slovakia
Prior art keywords
apoptin
cells
apoptosis
transformed
rad
Prior art date
Application number
SK1428-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK142899A3 (en
Inventor
Matheus Hubertus Maria Noteborn
Alexandra Maria Pietersen
Original Assignee
Leadd B. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97201121A external-priority patent/EP0872552A1/en
Application filed by Leadd B. V. filed Critical Leadd B. V.
Publication of SK142899A3 publication Critical patent/SK142899A3/sk
Publication of SK285724B6 publication Critical patent/SK285724B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1428-99A 1997-04-15 1998-04-15 Použitie adenovírusového génového nosiča schopného indukovať apoptózu v bunke na prípravu liečiva na liečenie transformovaných buniek a na prípravu diagnostického prostriedku na diagnostikovanie transformovaných buniek SK285724B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201121A EP0872552A1 (en) 1997-04-15 1997-04-15 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or Apoptin
EP97203595A EP0878546A1 (en) 1997-04-15 1997-11-18 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
PCT/NL1998/000213 WO1998046760A1 (en) 1997-04-15 1998-04-15 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin

Publications (2)

Publication Number Publication Date
SK142899A3 SK142899A3 (en) 2000-06-12
SK285724B6 true SK285724B6 (sk) 2007-07-06

Family

ID=26146368

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1428-99A SK285724B6 (sk) 1997-04-15 1998-04-15 Použitie adenovírusového génového nosiča schopného indukovať apoptózu v bunke na prípravu liečiva na liečenie transformovaných buniek a na prípravu diagnostického prostriedku na diagnostikovanie transformovaných buniek

Country Status (17)

Country Link
EP (2) EP0878546A1 (cs)
JP (1) JP2001521387A (cs)
KR (1) KR100528755B1 (cs)
AT (1) ATE275200T1 (cs)
AU (1) AU750162B2 (cs)
BR (1) BR9808542A (cs)
CA (1) CA2286165C (cs)
CZ (1) CZ299963B6 (cs)
DE (1) DE69825978T2 (cs)
DK (1) DK0975764T3 (cs)
ES (1) ES2227822T3 (cs)
NO (1) NO994967L (cs)
NZ (1) NZ500012A (cs)
PL (1) PL196607B1 (cs)
PT (1) PT975764E (cs)
SK (1) SK285724B6 (cs)
WO (1) WO1998046760A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4287588B2 (ja) * 1997-08-12 2009-07-01 レアト ベー．フェー． 作用因子の形質転換能力定量
MXPA01006998A (es) * 1999-01-11 2002-05-06 Leadd Bv Uso de agentes inductores de apoptosis en el tratamiento de enfermedades (auto) inmunitarias.
AU2004233486B2 (en) * 1999-01-11 2007-09-13 Leadd B.V. Use of apoptosis inducing agents in the treatment of (auto)immune diseases
PT1083224E (pt) * 1999-09-02 2007-03-30 Leadd Bv Proteína associada a apoptina
EP1081226A1 (en) * 1999-09-02 2001-03-07 Leadd B.V. Apoptin-associating protein
CA2393859A1 (en) * 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
ATE414776T1 (de) * 2001-03-30 2008-12-15 Leadd Bv Fusionsproteine zur spezifisichen behandlung von krebs und autoimmunkrankheiten
KR100561985B1 (ko) 2004-07-03 2006-03-22 고려대학교 산학협력단 종양 특이적 아폽틴 발현 카세트 및 이를 포함하는아데노바이러스 발현 벡터
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
CN109111527B (zh) * 2018-08-03 2022-03-15 沈阳金石生物制药有限公司 靶向特异性诱导肿瘤细胞凋亡的gip34-vp3融合蛋白及其制备方法和应用
CN109266714A (zh) * 2018-10-12 2019-01-25 广州医科大学 一种循环肿瘤细胞的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel

Also Published As

Publication number Publication date
AU750162B2 (en) 2002-07-11
BR9808542A (pt) 2000-05-23
NZ500012A (en) 2001-04-27
ATE275200T1 (de) 2004-09-15
JP2001521387A (ja) 2001-11-06
KR100528755B1 (ko) 2005-11-15
KR20010006460A (ko) 2001-01-26
DE69825978T2 (de) 2005-09-15
EP0878546A1 (en) 1998-11-18
NO994967D0 (no) 1999-10-12
CA2286165C (en) 2009-02-03
AU6856398A (en) 1998-11-11
EP0975764A1 (en) 2000-02-02
CA2286165A1 (en) 1998-10-22
PT975764E (pt) 2004-11-30
CZ349399A3 (cs) 2000-02-16
PL196607B1 (pl) 2008-01-31
DE69825978D1 (de) 2004-10-07
WO1998046760A1 (en) 1998-10-22
PL336312A1 (en) 2000-06-19
NO994967L (no) 1999-12-15
DK0975764T3 (da) 2005-01-03
ES2227822T3 (es) 2005-04-01
CZ299963B6 (cs) 2009-01-07
SK142899A3 (en) 2000-06-12
EP0975764B1 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
JP3565859B2 (ja) 改良されたアデノウイルスおよびその使用法
CA2174556C (en) Recombinant p53 adenovirus methods and compositions
KR100449181B1 (ko) 유전자요법에사용할수있는사람의재조합아데노바이러스패키징시스템
US9493745B2 (en) Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
JPH11507240A (ja) 組み換えアデノウイルス及びアデノ随伴ウイルス、細胞株、並びに生産方法並びにその使用
SK285724B6 (sk) Použitie adenovírusového génového nosiča schopného indukovať apoptózu v bunke na prípravu liečiva na liečenie transformovaných buniek a na prípravu diagnostického prostriedku na diagnostikovanie transformovaných buniek
EP4048798B1 (en) Adenovirus comprising a modified adenovirus hexon protein
US7253150B1 (en) Gene delivery vehicle expressing the aptosis-inducing proteins VP2 and/or apoptin
US20030100116A1 (en) Canine adenovirus vectors for the transfer of genes in targeted cells
Zhang Adenoviral vectors: development and application
MXPA99009486A (en) A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090415